Hepatitis C Cases by Country
Discover detailed Hepatitis C statistics across 187 countries, including both active cases and treatment success data. Track global progress toward HCV elimination with our comprehensive database showing the impact of modern antiviral therapies worldwide.
Global Hepatitis C Statistics 2022
Hepatitis C (HCV) is a viral infection that causes liver inflammation, potentially leading to serious liver damage. Our comprehensive database presents detailed statistics from 187 countries, showing both active chronic Hepatitis C cases and total numbers including successfully treated patients, providing crucial insights into global treatment progress.
Unlike Hepatitis B, Hepatitis C can be cured with antiviral medications. Modern direct-acting antivirals (DAAs) have revolutionized HCV treatment, achieving cure rates exceeding 95% with treatment courses lasting 8-12 weeks. This breakthrough has transformed Hepatitis C from a chronic, life-threatening condition into a curable disease. Our data presents two key metrics: active chronic cases and total cases including those who have been successfully treated. The difference between these numbers reveals the remarkable impact of treatment programs worldwide, particularly in countries with robust healthcare systems and treatment access. The 2022 data reveals significant variations in both disease burden and treatment success. Pakistan reports the highest number of active cases with approximately 8.8 million people, followed by Russia (2.7 million) and Egypt (484,000). However, Egypt's total including treated cases reaches 4.3 million, demonstrating one of the world's most successful national Hepatitis C elimination programs. Eastern Mediterranean and European regions show varying levels of treatment coverage. Countries like Georgia and Iceland have achieved remarkable treatment success rates, while others continue to face challenges in providing universal access to DAA therapies. The Western Pacific region, including countries like Japan and Australia, has also made significant strides in HCV elimination efforts. The World Health Organization has set ambitious targets for Hepatitis C elimination by 2030, aiming for 90% reduction in new infections and 65% reduction in mortality. Many countries have developed national elimination strategies, focusing on improving diagnosis rates, ensuring treatment access, and preventing new infections among high-risk populations. Our interactive visualization allows you to compare active cases with total treated populations, analyze treatment success rates by country, and understand regional progress toward HCV elimination. This data is invaluable for healthcare professionals, researchers, policymakers, and public health advocates working toward a world free of Hepatitis C. The statistics presented are based on WHO estimates for 2022 and represent both the number of people living with chronic Hepatitis C infection and those who have achieved sustained virologic response (cure) through treatment. Regular monitoring of these trends helps evaluate the effectiveness of national and global elimination strategies.Understanding Hepatitis C and Treatment Success
Hepatitis C Cases by Country
#
1
8,790,812
10,794,232
2,022
2
2,663,597
2,807,219
2,022
3
1,392,645
1,404,685
2,022
4
1,349,056
1,357,901
2,022
5
1,250,706
1,303,336
2,022
6
1,065,843
1,157,817
2,022
7
890,997
963,512
2,022
8
691,928
700,145
2,022
9
678,258
703,699
2,022
10
535,868
693,314
2,022
11
516,676
533,985
2,022
12
511,036
531,211
2,022
13
484,523
4,328,245
2,022
14
476,477
497,450
2,022
15
448,150
778,615
2,022
16
442,797
444,445
2,022
17
432,499
432,523
2,022
18
427,470
430,092
2,022
19
424,996
430,103
2,022
20
398,610
398,610
2,022
21
383,180
426,777
2,022
22
374,514
394,350
2,022
23
356,043
356,324
2,022
24
309,159
314,618
2,022
25
293,845
306,981
2,022
26
289,279
293,151
2,022
27
288,767
317,435
2,022
28
273,188
288,704
2,022
29
261,968
269,978
2,022
30
257,189
285,945
2,022
31
243,978
245,403
2,022
32
242,440
242,892
2,022
33
217,242
256,580
2,022
34
211,999
214,696
2,022
35
211,114
211,413
2,022
36
205,380
236,870
2,022
37
203,665
213,514
2,022
38
198,612
201,315
2,022
39
196,671
196,671
2,022
40
183,160
206,158
2,022
41
182,952
182,962
2,022
42
170,824
177,663
2,022
43
170,319
172,436
2,022
44
165,254
167,660
2,022
45
163,992
177,063
2,022
46
159,493
162,399
2,022
47
157,542
175,178
2,022
48
153,690
158,659
2,022
49
147,255
156,491
2,022
50
142,921
142,921
2,022
51
140,273
140,811
2,022
52
136,999
136,999
2,022
53
136,081
142,941
2,022
54
133,727
140,426
2,022
55
130,380
209,367
2,022
56
129,880
131,530
2,022
57
128,501
190,095
2,022
58
125,566
135,145
2,022
59
120,135
125,400
2,022
60
120,082
120,355
2,022
61
117,953
117,953
2,022
62
111,828
114,296
2,022
63
108,210
108,210
2,022
64
103,759
105,087
2,022
65
103,262
103,267
2,022
66
101,947
101,947
2,022
67
100,920
124,150
2,022
68
99,576
99,604
2,022
69
97,936
204,418
2,022
70
96,623
99,313
2,022
71
92,900
92,900
2,022
72
88,916
155,188
2,022
73
73,675
76,887
2,022
74
72,090
75,881
2,022
75
71,450
73,908
2,022
76
66,794
66,794
2,022
77
66,593
67,032
2,022
78
66,199
67,050
2,022
79
64,279
65,109
2,022
80
62,610
62,610
2,022
81
62,536
62,536
2,022
82
62,271
65,807
2,022
83
62,170
118,841
2,022
84
57,756
58,253
2,022
85
56,578
58,144
2,022
86
54,692
68,734
2,022
87
54,676
54,676
2,022
88
53,466
54,080
2,022
89
53,036
63,210
2,022
90
48,600
126,073
2,022
91
46,261
46,261
2,022
92
44,056
48,541
2,022
93
42,170
44,722
2,022
94
41,888
43,641
2,022
95
40,418
50,484
2,022
96
40,000
40,000
2,022
97
39,618
40,134
2,022
98
37,632
38,682
2,022
99
35,557
36,009
2,022
100
31,353
32,286
2,022
101
30,720
42,392
2,022
102
30,583
30,845
2,022
103
30,456
30,458
2,022
104
30,000
30,000
2,022
105
29,788
45,063
2,022
106
27,836
28,637
2,022
107
27,407
27,407
2,022
108
26,787
29,239
2,022
109
25,650
25,650
2,022
110
24,372
25,633
2,022
111
23,820
28,468
2,022
112
22,410
22,410
2,022
113
21,012
24,957
2,022
114
20,829
21,007
2,022
115
20,745
30,719
2,022
116
20,000
20,000
2,022
117
19,212
21,362
2,022
118
18,451
31,320
2,022
119
18,188
18,248
2,022
120
17,984
17,984
2,022
121
17,219
17,844
2,022
122
17,020
17,703
2,022
123
16,989
22,255
2,022
124
16,178
16,178
2,022
125
15,949
16,606
2,022
126
15,727
15,930
2,022
127
15,679
18,540
2,022
128
15,473
18,370
2,022
129
15,035
15,036
2,022
130
14,771
14,798
2,022
131
14,397
14,426
2,022
132
12,759
12,759
2,022
133
12,423
12,423
2,022
134
10,690
10,762
2,022
135
10,406
10,476
2,022
136
9,975
9,975
2,022
137
9,354
9,688
2,022
138
9,312
9,375
2,022
139
9,164
28,912
2,022
140
8,551
8,552
2,022
141
7,844
7,844
2,022
142
7,665
9,017
2,022
143
7,466
7,777
2,022
144
7,388
7,773
2,022
145
7,293
7,293
2,022
146
7,136
7,452
2,022
147
6,183
6,183
2,022
148
5,539
5,825
2,022
149
4,959
5,134
2,022
150
4,838
4,872
2,022
151
4,648
5,514
2,022
152
4,377
4,437
2,022
153
3,798
3,930
2,022
154
3,048
3,048
2,022
155
2,859
2,980
2,022
156
2,515
2,604
2,022
157
2,504
2,589
2,022
158
2,056
2,056
2,022
159
1,847
1,959
2,022
160
1,718
1,781
2,022
161
1,695
1,718
2,022
162
1,353
1,353
2,022
163
1,318
2,380
2,022
164
1,243
1,243
2,022
165
1,216
1,216
2,022
166
1,098
1,138
2,022
167
1,078
1,078
2,022
168
1,050
1,050
2,022
169
982
982
2,022
170
769
796
2,022
171
700
700
2,022
172
694
694
2,022
173
632
655
2,022
174
591
616
2,022
175
575
595
2,022
176
456
466
2,022
177
415
415
2,022
178
299
306
2,022
179
279
1,253
2,022
180
241
384
2,022
181
180
180
2,022
182
170
170
2,022
183
126
126
2,022
184
113
113
2,022
185
110
180
2,022
186
102
166
2,022
187
19
19
2,022
Global Distribution and Treatment Progress
The Path to Elimination
Using This Data
Frequently Asked Questions
Q: What is the difference between active Hepatitis C cases and total including cured?
A: Active cases represent people currently living with chronic Hepatitis C infection who require treatment or monitoring. The "total including cured" number adds those who have been successfully treated and achieved sustained virologic response (SVR), meaning the virus is no longer detectable in their blood. The difference between these numbers shows treatment success. For example, Egypt has 484,523 active cases but 4,328,245 total including cured, meaning approximately 3.8 million people have been successfully treated. This demonstrates the effectiveness of modern direct-acting antiviral therapies and national elimination programs.
Q: Can Hepatitis C be completely cured, and how effective are current treatments?
A: Yes, Hepatitis C can be completely cured with modern antiviral medications. Direct-acting antivirals (DAAs), introduced in the 2010s, have cure rates exceeding 95% with treatment courses lasting just 8-12 weeks. These medications work by targeting specific proteins the virus needs to replicate. Once cured (achieving sustained virologic response), the virus is eliminated from the body, though patients should continue liver monitoring if they had advanced disease. Unlike Hepatitis B, there is no chronic carrier state after successful HCV treatment. The main challenges now are ensuring diagnosis and treatment access, particularly in low-resource settings, rather than treatment efficacy itself.
Data Disclaimer: Projected data (future years) are estimates based on mathematical models. Actual values may differ. Learn about our methodology →
Sources
-
Updated: 07.11.2025https://www.who.int/data/gho/data/indicators/indicator-details/GHO/hepatitis---number-of-persons-living-with-chronic-hepatitis
Please log in to leave a comment.
Log in
(0) Comments